Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€2.78

€2.78

-1.420%
-0.04
-1.420%
-

-

 
12.05.21 / Tradegate WKN: A2P8AS / Name: InMed Pharma / Stock / Biotechnology & Medical Research / Small Cap /

InMed Pharmaceuticals Inc. Stock

A loss of -1.420% shows a downward development for InMed Pharmaceuticals Inc..

Pros and Cons of InMed Pharmaceuticals Inc. in the next few years

Pros
?
Shareholder structure
?
Market Position
?
Brand
Cons
?
Growth compared to competition
?
Worthwhile Investment for the next years
?
Conscious of the environment
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of InMed Pharmaceuticals Inc. vs. its peers

Security Change (%) 1w 1m 1y YTD 3y 5y
InMed Pharmaceuticals Inc. -1.420% -4.138% 3.731% -56.732% 6.107% - -
Promis Neurosciences Inc -1.280% 5.532% 9.251% 27.835% 135.294% - -
Oncolytics Biotech -0.920% -11.475% -14.961% 15.508% 9.091% -57.100% -51.313%
Trillium Therapeutics 1.980% -9.739% -16.651% 29.418% -34.093% - -

Other discussions about InMed Pharmaceuticals Inc. Stock

New thread Forum